Phathom Pharmaceuticals Inc. (PHAT) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Phathom Pharmaceuticals I...

    NASDAQ: PHAT · Real-Time Price · USD
    12.34
    0.34 (2.83%)
    At close: Sep 05, 2025, 3:59 PM
    12.35
    0.08%
    After-hours: Sep 05, 2025, 06:51 PM EDT

    Phathom Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.53 -2.32 -1.97 -4.91
    PEG Ratio
    		 -0.04 0.07 -0.05 19.71
    PS Ratio
    		 9.28 686.61 n/a n/a
    PB Ratio
    		 -2.02 -6.44 -5.87 10.09
    P/FCF Ratio
    		 -1.92 -3.36 -2.97 -4.89
    P/OCF Ratio
    		 -1.92 -3.4 -3 -4.9
    OCF/S Ratio
    		 -4.83 -201.73 n/a n/a
    Debt / Equity Ratio
    		 -2.19 -1.91 -1.3 1.27
    Quick Ratio
    		 4.16 10.22 6.12 9.86
    Current Ratio
    		 4.20 10.25 6.12 9.86
    Asset Turnover
    		 0.15 0.00 n/a n/a
    Interest Coverage
    		 -3.85 -3.99 -6.32 -19.9
    Return on Equity
    		 1.32 2.77 2.98 -2.05
    Return on Assets
    		 -0.88 -0.49 -1.35 -0.78
    Return on Invested Capital
    		 -0.95 -0.45 -1.39 -0.81
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.86 0.76 n/a n/a
    Net Profit Margin
    		 -6.05 -295.59 n/a n/a
    Pretax Profit Margin
    		 -6.05 -295.59 n/a n/a
    Operating Profit Margin
    		 -5.02 -245.33 n/a n/a
    FCF Margin
    		 -4.83 -204.13 n/a n/a
    EBITDA Margin
    		 -4.73 -233.21 n/a n/a

    Add to Watchlist